evaluated the risk of spontaneous cancer or cancers induced by the carcinogenic compound 7,12-dimethylbenz[a]anthracene using mouse models with a genetic variant on Chk2, a cell cycle checkpoint kinase activated in response to DNA damage and involved in cell cycle arrest and DNA damage repair (54). This evidence concerns the gene CHEK2 and cancer.